La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Dr. Hönle Gestione
Gestione criteri di controllo 0/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Markus Arendt
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | Nessun dato |
| Durata media del Consiglio di amministrazione | 1.9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%
Sep 26
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S
Aug 06Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?
Jul 02Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear
Feb 08We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt
Oct 11Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Aug 07Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 03The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence
Nov 03Dr. Hönle (ETR:HNL) Has No Shortage Of Debt
Sep 29There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital
Jul 06Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal
Feb 20Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 15Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 14Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?
May 30Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital
May 17Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)
Mar 29Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?
Mar 16We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt
Mar 03Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Feb 20
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide
Feb 08Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?
Jan 25Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?
Jan 11What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?
Dec 27Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 15Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?
Dec 03These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively
Nov 22AMMINISTRATORE DELEGATO
Markus Arendt
less than a year
Mandato
Dr. Markus Arendt is Managing Director and Chairman of the Management Board of Dr. Hönle AG from May 01, 2024 and serves as its Chief Executive Officer since 2024.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman of Supervisory Board | less than a year | €379.40k | Nessun dato | |
| Independent Deputy Chairman of Supervisory Board | 9.5yrs | €30.00k | Nessun dato | |
| Independent Member of Supervisory Board | 3.3yrs | €30.00k | Nessun dato | |
| Supervisory Board Member | less than a year | €43.00k | Nessun dato | |
| Independent Member of Supervisory Board | no data | Nessun dato | Nessun dato |
1.9yrs
Durata media
56yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di HNL non è considerato esperto (durata media del mandato 1.8 anni), il che suggerisce un nuovo consiglio.